M. A. Vlasova - Concepedia

Author

M. A. Vlasova

Kuopio University Hospital ORCID

Also Known As

M Vlasova, M. A. Vlasova, M. Vlasova, M.A. Vlasova, Maria A. Vlasova, Maria Vlasova, Mariia Vlasova

Publications

606

Citations

H-Index

Concepts

All Affiliations

Kuopio University Hospital University of Oulu University of Eastern Finland University of Turku Institute of Biomedical Chemistry

About

M. A. Vlasova is an author at Kuopio University Hospital specializing in biomedical engineering, engineering, and nanomedicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	4	4	244
2	Biomedical Engineering	4	4	244
3	Medicine	3	3	82
4	Public Health	1	1	38
5	Biochemistry	1	1	38

M. A. Vlasova

Publications

423

Citations

H-Index

Page 1

	Year	Citations
In vivo delivery of a peptide, ghrelin antagonist, with mesoporous silicon microparticles M. Kilpeläinen, Joakim Riikonen, M. A. Vlasova, Journal of Controlled Release NanomedicineEngineeringPeptide EngineeringPharmacologyMesoporous Silicon Microparticles	2009	135
Proteins and peptides of the salivary gland secretion of medicinal leeches Hirudo verbana, H. medicinalis, and H. orientalis I. P. Baskova, E. S. Kostrjukova, M. A. Vlasova, Biochemistry (Moscow)	2008	64
Nanostructured porous silicon microparticles enable sustained peptide (Melanotan II) delivery M. Kilpeläinen, Juha Mönkäre, M. A. Vlasova, European Journal of Pharmaceutics and Biopharmaceutics NanoparticlesNanomedicineEngineeringPeptide EngineeringMelanotan Ii	2010	63
Two-dimensional electrophoretic proteome study of serum thermostable fraction from patients with various tumor conditions Eugene Goufman, Sergei A. Moshkovskii, Olga V. Tikhonova, Biochemistry (Moscow)	2006	53
Acute phase serum amyloid A in ovarian cancer as an important component of proteome diagnostic profiling Sergei A. Moshkovskii, M. A. Vlasova, Mikhail A. Pyatnitskiy, PROTEOMICS - CLINICAL APPLICATIONS DiagnosisPathologyGynecologyOvarian CancerProteomic Technology	2006	38
Biocompatible photocrosslinked poly(ester anhydride) based on functionalized poly(ε-caprolactone) prepolymer shows surface erosion controlled drug release in vitro and in vivo Juha Mönkäre, Risto Hakala, M. A. Vlasova, Journal of Controlled Release EngineeringPolymer-drug ConjugateEster AnhydridePolymer ScienceDrug Delivery Systems	2010	26
Cardiovascular effects of ghrelin antagonist in conscious rats M. A. Vlasova, Kristiina Järvinen, Karl‐Heinz Herzig Regulatory Peptides HypertensionCardiovascular DiseasePhysiologyCardiovascular PharmacologyGhrelin Antagonist	2009	24
Injected nanoparticles: The combination of experimental systems to assess cardiovascular adverse effects M. A. Vlasova, Joakim Riikonen, Janne Raula, European Journal of Pharmaceutics and Biopharmaceutics NanoparticlesNanomedicineEngineeringCardiovascular Adverse EffectsCardiovascular Disease	2014	20

Page 1